XML 48 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
INTANGIBLE ASSETS (Details Narrative)
3 Months Ended
Mar. 31, 2018
USD ($)
Number
Mar. 31, 2017
USD ($)
Finite-Lived Intangible Assets [Line Items]    
Amortization expense | $ $ 21,197 $ 16,099
Approved Hormone Therapy Drug Candidate Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Useful Life 20 years  
Domestic U.S. Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Number of issued patents 18  
Foreign Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Number of issued patents 16  
Domestic Utility Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Number of issued patents 13  
Domestic Patents - TX-004HR [Member]    
Finite-Lived Intangible Assets [Line Items]    
Number of issued patents 3  
Domestic Utility Patent - Pipeline Transdermal Patch Technology [Member]    
Finite-Lived Intangible Assets [Line Items]    
Number of issued patents 1  
Domestic Utilty Patent - Opera Software [Member]    
Finite-Lived Intangible Assets [Line Items]    
Number of issued patents 1